BioNTech SE ADR (BNTX) Social Stream



BioNTech SE ADR (BNTX): $167.68

0.66 (+0.40%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add BNTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 380

in industry

BIONTECH SE (BNTX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering BNTX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 6 $450 $146 $275.666 $154.85 78.02%
2021-11-29 6 $450 $146 $278.666 $154.85 79.96%
2021-12-15 6 $450 $146 $279.555 $154.85 80.53%
2021-12-16 7 $450 $146 $281 $154.85 81.47%
2022-01-11 7 $450 $146 $281.6 $154.85 81.85%
2022-01-18 7 $450 $146 $280.6 $154.85 81.21%
2022-01-26 7 $450 $146 $274 $154.85 76.95%
2022-02-14 7 $450 $146 $267.3 $154.85 72.62%
2022-03-18 7 $450 $146 $264.6 $154.85 70.88%
2022-03-31 7 $450 $146 $271.5 $154.85 75.33%
2022-04-05 7 $339 $146 $247.1 $154.85 59.57%
2022-04-12 7 $339 $146 $245.1 $154.85 58.28%
2022-05-10 7 $300 $146 $240.9 $154.85 55.57%
2022-05-18 8 $300 $146 $240.7 $154.85 55.44%
2022-05-24 9 $350 $146 $246.916 $154.85 59.45%
2022-06-21 9 $350 $183 $256.09 $154.85 65.38%
2022-07-15 10 $350 $183 $240.7 $154.85 55.44%
2022-07-29 10 $350 $183 $240.8 $154.85 55.51%
2022-08-08 10 $350 $192 $247.222 $154.85 59.65%
2022-08-09 10 $350 $194 $246.444 $154.85 59.15%
2022-08-13 10 $350 $194 $245.222 $154.85 58.36%
2022-08-18 11 $350 $177 $238.4 $154.85 53.96%
2022-09-17 10 $350 $177 $226.7 $154.85 46.4%
2022-10-03 10 $350 $153 $224.3 $154.85 44.85%
2022-10-12 9 $350 $153 $224.3 $154.85 44.85%
2022-10-21 9 $350 $153 $224 $154.85 44.66%
2022-11-07 9 $350 $132 $218.9 $154.85 41.36%
2022-11-08 9 $350 $132 $216 $154.85 39.49%
2022-11-21 9 $350 $148 $217.6 $154.85 40.52%

The Trend in the Analyst Price Target


BNTX's average price target has moved up $171.83 over the prior 31 months.

BNTX reports an average of 50.33% for its upside potential over the past 51 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-02-01 7 450 146 267.300 179.60 48.83%
2022-03-31 7 450 146 271.500 170.56 59.18%
2022-05-24 9 350 183 256.090 154.50 65.75%
2022-07-29 9 350 192 247.222 165.15 49.7%
2022-11-21 9 350 148 217.600 158.41 37.37%

BNTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.11 4 0 5 0 0 9

The Trend in the Broker Recommendations


BNTX's average broker recommendation rating worsened by 0.11 over the prior 32 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how BIONTECH SE fares relative to all US stocks, note that its average analyst price target is greater than 3504.13% of that group.
  • BIONTECH SE's variance in analysts' estimates is lower than -3057.39% of stocks in the large market cap category.
  • To contextualize these metrics, consider that out of stocks in the large market cap category, BIONTECH SE's number of analysts covering the stock is higher than 870.61% of them.
  • In terms of how BIONTECH SE fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1028.92% of that group.

In the Pharmaceutical Products industry, MRNA, GILD, and BIIB are the three stocks most similar to BIONTECH SE regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding BNTX using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6112 seconds.